1887

Abstract

SUMMARY

When transformed human embryonic cells, RSa and RSb, were treated for 48 h with both 10 -ouabain and 1000 units/ml of human leucocyte interferon, there was an additive suppression of cell growth. In contrast, the antiviral action of the human interferon was inhibited by this concentration of ouabain. Similar effects of combined treatment with interferon and ouabain were found with IF cells (which are relatively resistant to the anticellular effect of interferon), and with mouse cells of the K3b line.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-34-3-537
1977-03-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/34/3/JV0340030537.html?itemId=/content/journal/jgv/10.1099/0022-1317-34-3-537&mimeType=html&fmt=ahah

References

  1. Adams A., Strander H., Cantell K. 1975; Sensitivity of the Epstein Barr virus transformed lymphoid cell lines to interferon. Journal of General Virology 28:207–217
    [Google Scholar]
  2. Dahl H., Degré M. 1975; Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature, London 257:799–901
    [Google Scholar]
  3. De Clercq E., Stewart W. E. II. 1973; The breadth of interferon action. In Selective Inhibitors of Viral Functions pp. 81–106 Edited by Carter W. A. Cleveland: CRC Press;
    [Google Scholar]
  4. Fuchsberger N., Hajnicka V., Borecky L. 1975; Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions. Acta Virologica 19:59–66
    [Google Scholar]
  5. Fuse A., Kuwata T. 1976; Effect of interferon on the human clonal line, RSa cells: inhibition of macromolecular synthesis. Journal of General Virology 33:17–24
    [Google Scholar]
  6. Gresser I. 1972; Antitumor effects of interferon. Advances in Cancer Research 16:97–140
    [Google Scholar]
  7. Kuwata T., Fuse A., Morinaga N. 1976; Effect of interferon upon cell and virus growth in transformed human cell lines. Journal of General Virology 33:7–15
    [Google Scholar]
  8. Kuwata T., Okazaki T., Spahn G. J. 1973; Virogenic properties of AKR mouse sarcoma cells induced by Rous sarcoma virus. Archiv für die gesamte Virusforschung 41:106–115
    [Google Scholar]
  9. Lebon P., Moreau M.-C. 1973; Inhibition de l’áction de l’interféron par l’ouabáine. Compte Rendu Hebdomadaire des seances de l’Academie des Sciences 276 D:3061–3064
    [Google Scholar]
  10. Lebon P., Moreau M.-C. 1975; Effect of ouabain on the action and production of interferon. In Effects of Interferon on Cells, Viruses and the Immune System Edited by Geraldes A. pp. 325–333 New York: Academic Press;
    [Google Scholar]
  11. Lebon P., Moreau M.-C., Cohen L., Chany C. 1975; Different effect of ouabain on interferon production and action. Proceedings of the Society for Experimental Biology & Medicine 149:108–112
    [Google Scholar]
  12. Matsuzawa I., Kawade Y. 1974; Cell growth inhibitory activity of electrophoretic fractions of L-cell interferon preparation. Acta Virologica 18:383–390
    [Google Scholar]
  13. Mayhew E., Levinson C. 1968; Reversibility of ouabain induced inhibition of cell division and cation transport in Ehrlich ascites cells. Journal of Cellular Physiology 72:73–76
    [Google Scholar]
  14. McDonald I. F., Sachs H. G., Orr C. W. M., Ebert J. D. 1972; Multiple effects of ouabain on BHK cells. Experimental Cell Research 74:201–206
    [Google Scholar]
  15. Quastel M. R., Kaplan J. G. 1970; Lymphocyte stimulation: the effect of ouabain on nucleic acid and protein synthesis. Experimental Cell Research 62:407–420
    [Google Scholar]
  16. Shank B. B., Smith N. E. 1975; Regulation of cellular growth by sodium pump activity. Journal of Cellular Physiology 87:377–388
    [Google Scholar]
  17. Stewart W. E. II, De Clercq W., De Somer P., Berg K., Ogburn C. A., Paucker K. 1973; Antiviral and nonantiviral activity of highly purified interferon. Nature New Biology 246:141–143
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-34-3-537
Loading
/content/journal/jgv/10.1099/0022-1317-34-3-537
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error